ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,137.73
-0.55%
Dow Jones
40,211.72
0.53%
Gold vs US Dollar
2,433.28
0.46%
Brent Oil
83.715
-0.74%
Bitcoin
62,988.93
-2.87%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Allos Therapeutics, Inc. (MM) (ALTH)

  7. Allos Therapeutics, Inc. (MM) (ALTH) News

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
29/01/201021:09Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
19/01/201020:53Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/01/201000:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
12/01/201000:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/01/201023:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
06/01/201013:00Business WireAllos Therapeutics to Present at J.P. Morgan Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/01/201022:33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/12/200911:25MarketwiredWall St Sense Offers In-depth Research on the Services, Financial and Healthcare Sectors' Key PlayersNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/12/200914:31Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
08/12/200914:15Business WireAllos Therapeutics’ FOLOTYN™ Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Ly...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200918:22Dow Jones News2nd UPDATE: Celgene To Buy Gloucester Pharma for At Least $340 MillionNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200915:00Business WireAllos Therapeutics’ FOLOTYN™ Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Tre...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
07/12/200913:41Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/12/200915:00Business WireAllos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN™ at 51st ASH Annual MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/12/200913:11Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/12/200913:00Business WireAllos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN™ (pralatrexate injection)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200920:04Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/12/200913:00Business WireAllos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematolo...NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200921:07Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/11/200913:00Business WireAllos Therapeutics Announces Issuance of U.S. Patent for FOLOTYNNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/11/200911:38MarketwiredRidgewater Equity Reviews the Following Equities Human Genome Sciences Inc., Intuit Inc., Advanced Battery Technologies, Linn EnNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200913:00Business WireAllos Therapeutics Announces New Data on FOLOTYN™ to be Presented at the American Society of Hematology MeetingNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
11/11/200911:54MarketwiredAnalystChoice.com Provides Analytical Coverage on ELNK, NWSA, NTAP, ALTH, HANS and BPOPNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200914:51Business WireAllos Therapeutics to Present at Upcoming Conferences in NovemberNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200921:11Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/11/200921:01Business WireAllos Therapeutics Reports Third Quarter 2009 Financial ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/11/200910:12MarketwiredGlobal Market Perspective Review on ALTH, CINF, ALKS, DBRN, APOL and INFY from TheFortuneFinancial.comNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
26/10/200912:00Business WireAllos Therapeutics to Report Third Quarter 2009 Results on November 3, 2009NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/10/200911:57MarketwiredBenchmarkJournal.com Provides Sector & Company Analysis on OMC, PSE, PWR, ALTH, NWSA and ELNKNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
13/10/200921:23Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

LSE
FLOT
Is $ Flt Rte Bd
NASDAQ
AGIO
Agios Pharmaceuticals
NYSE
CIR
CIRCOR
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved